Thursday, December 19th, 2024

Rimbunan Sawit on the Rise: Bulls Gear Up for Breakout

Date: October 15, 2024
Broker Name: CGS International


Stock Overview

Rimbunan Sawit (Stock Code: 5113) is involved in the cultivation of oil palms and processing of palm oil. The company owns approximately 13,500 hectares of plantation land and operates its own palm oil mill, positioning itself as a significant player in Malaysia’s palm oil industry.


Technical Analysis

As of October 15, 2024, the stock price of Rimbunan Sawit is RM0.25. The stock has been closing at its day’s high for the last few sessions, which is a positive signal for near-term momentum. After a period of consolidation over the past five months, the stock appears poised for a breakout.


Key Support and Resistance Levels

  • Entry Price: RM0.245 to RM0.25
  • Support Levels: RM0.230 (Support 1), RM0.215 (Support 2)
  • Resistance Levels: RM0.270 (Resistance 1), RM0.285 (Resistance 2)
  • Stop Loss: RM0.225

Target Prices

Rimbunan Sawit is targeting an upward breakout, with potential price targets set at RM0.270 and RM0.285. The 52-week high of RM0.285 serves as a key resistance level that traders will watch closely.


Technical Indicators

  • Moving Average Convergence Divergence (MACD): Showing signs of easing pressure, indicating that bearish momentum is weakening.
  • Relative Strength Index (RSI): The RSI has hooked up again, potentially signaling that the bulls are preparing for a charge upwards.

Investment Strategy

CGS International suggests that aggressive traders may want to consider going long on Rimbunan Sawit either at current levels or on weakness, with a stop-loss set at RM0.225. The stock is showing signs of an upcoming breakout to test the July high of RM0.27 and the 52-week high of RM0.285.

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024Broker: CGS-CIMB Securities Malaysia Sdn. Bhd. Company Overview Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and...

MBB Bank: Vietnam’s Growth Engine with 38% Upside Potential and 21%+ ROE

In-Depth Analysis of MBB Bank: A Comprehensive Financial Review In-Depth Analysis of MBB Bank: A Comprehensive Financial Review Broker Name: Maybank Securities Limited Date of Report: November 11, 2024 Overview MBB Bank, a quasi-state-owned...

Civmec: Capitalizing on Record Tender Opportunities for Sustainable Growth

Date of Report: 3 October 2024Broker: UOB Kay Hian Record Tender Opportunities Civmec is currently experiencing historically high levels of tendering activities across its operations, with current priced opportunities approaching A$10 billion. The company...